2002•PubMedRequires access

[Hypolipidemic drugs--ileal Na+/bile acid cotransporter inhibitors (S-8921 etc)].

Teruhisa Ichihashi

Open publisher page 1 citations

Abstract

The ileal Na+/bile acid cotransporter (IBAT) maintains the reabsorption of bile acids from the ileum in the enterohepatic circulation of bile acids. Interruption of the enterohepatic circulation of bile acids by bile acid sequestrants or partial ileal bypass surgery can cause a significant decrease of serum cholesterol in animals and human patients. Inhibition of IBAT by specific IBAT inhibitors such as S-8921 has been proven to lower serum cholesterol in a variety of experimental animals. IBAT inhibitors, a new class of hypocholesterolemic drugs may be used alone or in combination with HMG-CoA reductase inhibitors in the treatment of hypercholesterolemia with low dosage and high compliance.

About this research paper

What this paper is about

The ileal Na+/bile acid cotransporter (IBAT) maintains the reabsorption of bile acids from the ileum in the enterohepatic circulation of bile acids. Interruption of the enterohepatic circulation of bile acids by bile acid sequestrants or partial ileal bypass surgery can cause a significant decrease of serum cholesterol in animals and human patients. Inhibition of IBAT by specific IBAT inhibitors such as S-8921 has been proven to lower serum cholesterol in a variety of experimental animals. IBAT inhibitors, a new class of hypocholesterolemic drugs may be used alone or in combination with HMG-CoA reductase inhibitors in the treatment of hypercholesterolemia with low dosage and high compliance.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The ileal Na+/bile acid cotransporter (IBAT) maintains the reabsorption of bile acids from the ileum in the enterohepatic circulation of bile acids. Interruption of the enterohepatic circulation of bile acids by bile acid sequestrants or partial ileal bypass surgery can cause a significant decrease of serum cholesterol in animals and human patients. Inhibition of IBAT by specific IBAT inhibitors such as S-8921 has been proven to lower serum cholesterol in a variety of experimental animals. IBAT inhibitors, a new class of hypocholesterolemic drugs may be used alone or in combination with HMG-CoA reductase inhibitors in the treatment of hypercholesterolemia with low dosage and high compliance.

Key concepts: Enterohepatic circulation, Bile acid, Reabsorption, Internal medicine, Ileum, Cholesterol, Cholesterol 7 alpha-hydroxylase, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
[Hypolipidemic drugs--ileal Na+/bile acid cotransporter inhibitors (S-8921 etc)]. — Research Paper | ScholarLens